The market is still in the early days for blood vessel wholesalers, and there’s a lot of uncertainty about the role of traditional blood vessel manufacturers.
But a new study by a team of researchers from the University of Oxford and Imperial College London offers an update on the market.
The team, led by Professors Jonathan Pardue and Chris Jones, said their findings, which were recently published in the peer-reviewed journal PLOS ONE, suggest that blood vessel supply chain stakeholders need to consider the following: What is the optimal supply chain for a given product?